Science

Model Informed Drug Development

We take a modern scientific approach to drug development by utilizing human clinical data to develop exposure-based, biological, and statistical models for identifying new uses of existing drugs.

Two young scientists image on the AltaThera Website

Leaning on the Power of Numbers to Predict Drug Safety

Our model-informed drug development methods aim to identify safety signals or rare adverse events that may not be detected in clinical trials.

Benefits for Pediatric Drug Development

Our quantitative methods account for the maturation and physiological changes of children and help develop dosing models for different age groups.
Nurse talking to a girl on the patient section of Altathera website

Investigator Initiated Studies

At AltaThera, we are committed to developing the right dose, for the right patient, at the right time. The value of investigator-initiated research is a critical complement to AltaThera-sponsored research and may help us better understand the benefits and risks of our therapies. Contact us today if you would like to discuss your research interests in detail.

Visit clinicaltrials.gov to learn more about studies pertaining to AltaThera, Sotalol IV, and our Model-informed Drug Development.